MARATTO

article · Cureus

Unclassifiable Renal Cell Carcinoma With an Estimated 100% Sarcomatoid Component: A Case Report

20241 citationOpen accessMohamed I University

Abstract

Sarcomatoid renal cell carcinoma (RCC) is an aggressive tumour with a poor prognosis. It is not a distinct histological entity, as it can be found in any subtype of renal cell carcinoma. The majority of cases will present with advanced or metastatic disease requiring systemic treatment. However, pathologists are sometimes confronted with renal cell tumours that do not fit any definition, so these tumours must be considered unclassified renal cell carcinomas. The criteria for this classification are varied and include tumours with more than one histological subtype, tumours with unrecognized epithelial histological subtypes, mucin-producing tumours, and tumours with an exclusively sarcomatoid or rhabdoid morphology. The latter subgroup of unclassified renal cell carcinomas is rare in renal pathology. Consequently, the presence and quantity of the sarcomatoid component must be reflected in pathology reports. We report the case of a 76-year-old male patient presenting with intermittent left lumbar pain for two months, in a deteriorating general condition. Histological and immunohistochemical examinations revealed an unclassifiable renal cell carcinoma with an estimated 100% sarcomatoid component.

Research topics

  • Renal cell carcinoma treatment
  • Bladder and Urothelial Cancer Treatments
  • Cancer Diagnosis and Treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.7759/cureus.74984

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.